Stipple Bio is connecting the dots…
Stipple Bio is connecting the dots toward multiple early-stage clinical [...]
After emerging from stealth last…
After emerging from stealth last month with $175 million in [...]
Oric Pharmaceuticals has picked…
Oric Pharmaceuticals has picked the phase 3 dose for its [...]
Have we passed the peak of biotech…
Have we passed the peak of biotech layoffs? It’s too [...]
Half a year after being spurned by…
Half a year after being spurned by the FDA and [...]
Ambrosia Biosciences is aiming to…
Ambrosia Biosciences is aiming to move the market beyond peptide-based [...]
Eli Lilly has gone big in the name…
Eli Lilly has gone big in the name of neuroscience, [...]
Astellas Pharma has become the…
Astellas Pharma has become the latest company to pull back [...]
One of the world’s leading…
One of the world’s leading investment firms has broken its [...]
Autoimmune specialist Aurinia,…
Autoimmune specialist Aurinia, which named Kevin Tang as its new [...]